Indian Phosphate
Indian Phosphate Q2 FY26: Revenue ₹451 Cr
Q2 FY26 earnings call: what management guided on revenue, margins and order book.
What the Q2 FY26 call signalled
2 of 3 strong
The short version
H1 FY 25-26 revenue increased by ~15% to ₹451 crores versus ₹385 crores in H1 FY 24-25. The company expects improvement in both top line and bottom line due to the commissioning of the Labsa and sulfuric acid plants by FY27, leading to better integrated operations and cost efficiencies.
From Indian Phosphate's Q2 FY26 earnings-call transcript · updated 26 Aug 2026.
Revenue & Sales Performance
- H1 FY 25-26 revenue increased by ~15% to ₹451 crores versus ₹385 crores in H1 FY 24-25.
- EBITA rose by 40% in H1 FY 25-26 compared to the previous year.
- Fertilizer segment expected to improve due to favorable government subsidy restoration.
- Chemical segment highly diversified, contributing 90% of revenue; expected continued growth with diversification plans.
- Tamil Nadu Labsa plant commissioning anticipated in FY 26-27, expected to add significant turnover and revenue.
- Sulfur price volatility impacts revenue, but higher sulfur prices have boosted revenue from sulfuric acid.
- Sulfuric acid plant capacity utilization currently around 75%, with aggressive sales plans.
2 more points from Indian Phosphate's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Indian Phosphate said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company is prioritizing the commissioning and operation of its Tamil Nadu Kadlar plant (Labsa plant) in the current financial year, expecting full operations by FY27.
- After the Kadlar plant is operational, focus will shift to the Dhule fertilizer plant; however, there is currently no set timeline for its commissioning.
- The Dudule sulfuric acid plant was commissioned recently and is operational, contributing to revenues in H1 of the current financial year.
- The Dhule plant construction is approximately 60-65% completed, with completion and commissioning expected in the third or fourth quarter of the next financial year (FY27).
2 more points from Indian Phosphate's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Indian Phosphate said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Indian Phosphate's call on order book
Pro opens every point from 15K+ earnings calls
Continue your research
What Indian Phosphate's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Gujarat Alkalies (Q2 FY26)
2,136.64 Crores (Page 21). Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q2 FY26 investor presentation — and how it ranks against
- Platinum Industries Ltd (Q2 FY26)
Q2FY26 Revenue from Operations (Consolidated): INR 983.8 Mn, down 1% YoY from INR 996.4 Mn in Q2FY25. Key investor presentation takeaways from Platinum Industri
- Galaxy Surfactants Ltd (Q2 FY26)
Capital Work-in-Progress (CWIP) was around INR 260 crores as of FY '25. Key concall takeaways from Galaxy Surfactants Ltd's Q2 FY26 earnings call — and how it…
- Aether Industries Ltd (Q2 FY26)
EBITDA margins are sustainable at 29%-30%, supported by increasing contract manufacturing and CRAMS business. Key concall takeaways from Aether Industri.'s Q2…
Arthneeti Pro · Annual
Indian Phosphate and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Indian Phosphate Q2 FY26 results?
H1 FY 25-26 revenue increased by ~15% to ₹451 crores versus ₹385 crores in H1 FY 24-25. The company expects improvement in both top line and bottom line due to the commissioning of the Labsa and sulfuric acid plants by FY27, leading to better integrated operations and cost efficiencies.
What is Indian Phosphate share price analysis?
Indian Phosphate currently shows a below-average growth signal. The stock trades at a P/E of 7.6 with a market cap of ₹167 Cr. Investors should review the full earnings analysis for detailed insights.
Is Indian Phosphate planning capital expenditure?
The company is prioritizing the commissioning and operation of its Tamil Nadu Kadlar plant (Labsa plant) in the current financial year, expecting full operations by FY27.
Keep Indian Phosphate on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.